Mark Seidler


Dr. Mark Seidler, chief executive officer, joined Strategic Decisions Group in 2001 and has led the firm’s European operations since 2012. He has more than 20 years of experience in structuring and development of strategies for global leaders in pharmaceuticals, agrosciences, and fine chemicals in Europe, the U.S., and Asia.

Dr. Seidler’s experience spans a broad spectrum of interdisciplinary, international projects, including supporting clients in defining the focus of product development, business unit, and corporate strategy. He guides clients through major business transitions, including decisions to enter new geographic markets or business sectors, to align innovation and product portfolio strategy, and to transform business models in the face of industry change. He is broadly experienced in the application of decision analysis methodology as well as the structuring and modeling of complex strategic alternatives.

In the broader life sciences industry, he helps clients define product strategy for assets in all stages of development, value licensing candidates, and structure effective alliances. He has extensive experience in optimizing deal structure and negotiation strategy and in developing robust lifecycle management strategies for products facing loss of exclusivity. In addition, he advises clients in the allocation of marketing resources across major brands in key markets and business process improvement.

Prior to entering consulting, Dr. Seidler held a variety of positions at Bayer AG in Germany, both in business operations in product development and production, as well as in the pharmaceutical and corporate strategy departments.

Dr. Seidler holds a PhD in chemistry from the University of California at Berkeley and a BS in chemistry from the California Institute of Technology.